HSBC analyst Daniela Bretthauer downgraded Walgreens Boots Alliance to Reduce from Hold with a price target of $20, down from $27. The firm lowered estimates for 2024-26 and adopted a more conservative target multiple, citing structural headwinds in the company’s core pharmacy business, growing pains in the healthcare segment and cash flow pressures, the analyst tells investors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on WBA:
- Petco names Holly May as Chief Human Resources Officer
- Walgreens Announces Executive Appointment and Retirement
- Walgreens Announces Key Executive Appointments and Retirement
- Walgreens Boots Alliance appoints Elizabeth Burger as CHRO
- Cencora announces common share repurchase from Walgreens Boots Alliance
